SEC Form 4 research
| Issuer | Arcadia Biosciences, Inc. |
|---|---|
| Tickers | RKDA |
| Reporting owners | 44 |
| Officers and directors | 17 |
| Last public filing | 2026-09-14 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-14 | 2026-09-10 | Yoder Amy | A | 10,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-10 | Comcowich Kevin | A | 23,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-10 | WALLER GREGORY D | A | 10,000 | $0 | Not reported |
| 2026-09-14 | 2026-09-10 | Murray Lilian Shackelford | A | 10,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.